Joaquin Espinosa, PhD
Linda Crnic Institute for Down Syndrome, CU Anschutz · Linda Crnic Institute for Down Syndrome · University of Colorado, Denver
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joaquin Espinosa, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:57 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07598643 · Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1University of Colorado, Denver · recruiting · Down Syndrome · principal investigator
- Ph2NCT05662228 · Therapies for Down Syndrome Regression DisorderUniversity of Colorado, Denver · completed · Down Syndrome, Regression · principal investigator
- Ph2/Ph3NCT04348071 · Safety and Efficacy of Ruxolitinib for COVID-19University of Colorado, Denver · withdrawn · COVID-19 · principal investigator
- Ph2/Ph3NCT04340232 · Safety and Efficacy of Baricitinib for COVID-19University of Colorado, Denver · withdrawn · COVID-19 · principal investigator
- Ph2NCT04246372 · Tofacitinib for Immune Skin Conditions in Down SyndromeUniversity of Colorado, Denver · completed · Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema · principal investigator
- N/ANCT02864108 · The Human Trisome ProjectUniversity of Colorado, Denver · recruiting · Down Syndrome, Trisomy 21 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- JAK Inhibition in Down SyndromeR33AR077495 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Anna Lee Bruckner, Joaquin M. Espinosa, Emily Gurnee, Angela Lynn Rachubinski · fiscal years 2022 to 2024Named on NCT04246372
- Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI RONALD J. SOKOL · fiscal years 2013 to 2017Named on NCT02864108
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.